Torosa Saline Filled Testicular Prosthesis
Coloplast Corp. · Decision date Jul 21, 2026
What did the FDA decide?
FDA records P020003/S012 as a supplement to PMA P020003, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 21, 2026.
FDA approval order statement
to increase the amount of manufacturing cleanroom space by converting existing space into a new cleanroom, along with installing a deionized water system and clean dry air system in the cleanroom
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Jul 21, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P020003/S012
- Regulatory pathway
- PMA supplement
- Applicant
- Coloplast Corp.
- Product code
- FAF
- Decision code
- OK30
- Decision date
- Jul 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, testicular.
- Applicant
- Coloplast Corp.
- Product code
- FAF
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P020003/S012 received
Application receipt date recorded by FDA.
P020003/S012 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P020003. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Coloplast Corp.
- Headquarters
- Not reported
- Brand website
- coloplast.com
- FDA applicant address
- 1601 W. River Rd. N., Plymouth, MN, 55411
Sources and methodology
- Original FDA record: P020003/S012
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records